New CHCs: Native Estrogen with Specific Actions in Tissues (NEST) - a podcast by ReachMD

CME credits: 0.25

Valid until: 26-02-2022

Claim your CME credit at https://reachmd.com/programs/cme/new-chcs-native-estrogen-with-specific-actions-in-tissues-nest/12283/

The estrogen component of combined oral contraceptives in part helps to suppress FSH and folliculogenesis, stabilizes the endometrium, minimizes unscheduled bleeding, and supports progestin activity. Nonetheless, there are downsides to estrogen, including an increased risk for cardiovascular and thromboembolic adverse events such as pulmonary embolism and deep vein thrombosis.

Join Drs. Lee Shulman and Andrew Kaunitz as they envision a better oral contraceptive—one formulated with a high NEST activity estrogen that has less potential to increase the risk of thromboembolic events while maintaining good cycle control.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD